Analyst consensus rating
Standard BioTools Inc. Analyst Consensus Rating
LAB analyst consensus rating, coverage count and price target evidence.
Direct answer
Standard BioTools Inc.'s consensus rating is Hold.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $1.35.
Forecast evidence checked August 15, 2026.
Get free Standard BioTools Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.71
- Average price target
- $1.35
- High price target
- $1.35
- Low price target
- $1.35
- Target upside
- +89.5%
- Consensus rating
- Hold
- Analysts
- 1
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026